BLACK WEEKSHætteglas −15% · kits −10% · resten −5%med kodeGratis fragt i Tyskland fra €200

Denne side er oversat automatisk og kan indeholde fejl. Har du dansk som modersmål? Vi hører meget gerne din feedback og dine rettelser.Send feedback

The Peptide Desk The Peptide Desk
ACE-031, produktfoto
Muscle Building

ACE-031

Muscle Building

  • Sendes fra Tyskland

Bestilling

Stykpris - Gratis fragt i Tyskland fra 200 € under Black Weeks
  • DHL med sporing
  • Diskret emballage

4.6 ud af 5 på Trustpilot73 anmeldelser

Kort fortalt

ACE-031 i tal

Nøgletallene fra vores leksikon.

Hele leksikonopslaget
Class
ActRIIB-Fcmyostatin/activin trap
Half-life
longfusion protein
Use
Subcutaneousno established protocol
Sizes
1 mg1 size in the shop

Der er endnu ingen laboratorieanalyse for ACE-031. Stem på denFå det testet selv, vi betaler halvdelenAlle laboratorieanalyser

Viden

Alt om ACE-031

Godt at have

Det har du brug for til den

Bakteriostatisk vand lægges automatisk i din kurv. Sprøjter og servietter med ét klik.

Insulinsprøjter

10 stk. · 5.50 €

Spritservietter

50 stk. · 10 €

Hvor meget vand?

Enheder på sprøjten til din hætteglasstørrelse.

Åbn beregneren →

FAQ

Ofte stillede spørgsmål

Kilder til hvert svar: leksikonopslag

Har du stadig et spørgsmål?

Skriv til os, vores team hjælper dig.

What is ACE-031?

A large fusion protein: the outer part of the activin receptor IIB, linked to a piece of an antibody (IgG1 Fc). It binds myostatin and related messengers in the blood before they reach the receptor on muscle. The compound name is ramatercept.

What did the first human study show?

48 healthy postmenopausal women received a single dose at ascending levels or placebo. In the group with the highest study dose lean mass rose by 3.3 percent and thigh muscle volume by 5.1 percent after 29 days. The half-life was 10 to 15 days.

Why was development stopped?

In the trial in boys with Duchenne muscular dystrophy nosebleeds and telangiectasias occurred, meaning widened small blood vessels. The trial was stopped after the second dosing regimen because of potential safety concerns. The activin receptor IIB acts not only on muscle but also on vessels.

Was there a benefit in Duchenne?

Only trends. The 6-minute walk distance tended to be maintained in the ACE-031 groups while it declined on placebo. There were also trends towards more lean mass and bone density and less fat mass. None of this was statistically significant.

Is ACE-031 approved?

No. ChEMBL lists ramatercept with phase 2 as the highest phase. ClinicalTrials.gov lists four trials from 2008 to 2011, both phase 2 trials were terminated early (as of 26 October 2026).

What do animal studies show?

In marmosets lean mass increased over 14 weeks on ACE-031, muscle fibres became thicker and muscle force rose. This did not happen in the control group. The authors see this as a pointer for muscle diseases in humans.

Relateret

Relaterede produkter